Personalized vaccines spur hope for cancer patients

Jul 17, 2017, 7:46 AM EDT
(Source: Carlos Reusser Monsalvez/flickr)
(Source: Carlos Reusser Monsalvez/flickr)

Two research groups, working separately in the U.S. and Germany, have trialed personalized cancer vaccines on humans, an approach that experts believe could be a game-changer for cancer treatment.

The first results of the clinical trial on 13 patients showed that the process is potent in shrinking tumors, writes Research Gate. This approach is better than conventional treatment as each vaccine is tailored to the individual and their cancer cell’s unique genetic mutation.

Cornelis Melief, a cancer immunologist at Leiden University Medical Centre in the Netherlands calls the breakthrough “potentially a gamer changer,” notes The Scientist.